Transthyretin as a potential CSF biomarker for Alzheimer’s disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors

Quantitative Analysis of Transthyretin, Tau and Amyloid-β in Patients with Dementia

(2017) Sara Friederike Gloeckner et al.   JOURNAL OF ALZHEIMERS DISEASE

Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients

(2017) Sara F. Hansson et al.   JOURNAL OF ALZHEIMERS DISEASE

Transthyretin Accelerates Vascular Aβ Deposition in a Mouse Model of Alzheimer's Disease

(2008) Henny Wati et al.   BRAIN PATHOLOGY

Transthyretin in cerebrospinal fluid from suicide attempters

(2008) Kristofer Schultz et al.   JOURNAL OF AFFECTIVE DISORDERS

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases

(2008) Markus Otto et al.   METHODS

Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of A  toxicity

(2008) J. N. Buxbaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia